NEW YORK, March 11, 2014 – New York- based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Israel based Can-Fite BioPharma Ltd. (TASE CFBI and CANF NYSE MKT) an advanced clinical stage drug development company with its recently completed private placement of American Depository Receipts (“ADR’s”) each of which consist of two Ordinary Shares. The Company raised approximately $5 Million. Roth Capital Partners acted as the placement agent the offering. The Sichenzia Ross Friedman Ference LLP team was led by Gregory Sichenzia and Gary Emmanuel.
About Sichenzia Ross Friedman Ference LLP
Sichenzia Ross Friedman Ference LLP are corporate and securities lawyers that provide experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world.
